Non-invasive and radiation-free assessment for early rule-out of significant CAD.
On a Mission to Listen to Millions of Hearts
Introducing CADScor®System — an AI-powered acoustic diagnostic aid to rule out significant coronary artery disease in 10 minutes.*
Use CADScor®System to Rule-Out Significant CAD in Patients Experiencing Chest Pain or Shortness of Breath*
Can help save costs of more advanced CAD diagnostics in up to 35% of patients.¹
Rapid and easy-to-use, with clear results in 10 minutes.
Rule-Out significant CAD in Just 10 Minutes with at least 96% Confidence (Negative Predictive Value)¹
CADScor®System is a point-of-care diagnostic aid that uses highly sensitive acoustics and advanced AI to analyze the patient's coronary blood flow.² In just 10 minutes, it calculates a patient-specific CAD-score, and couples it with risk factors to indicate the patient’s risk of significant coronary stenosis. CADScor®System has been used in over 24,000 patient assessments³ and has CE-marking and FDA De Novo clearance.
Physicians’ Experiences Using CADScor®SystemExplore customer feedback
Schedule a Demo of CADScor®System
Schedule a free demo of CADScor®System and learn how to rule out significant CAD patients in 10 minutes.
Latest NewsSee all news
May 9, 2023
Acarix and the American College of Cardiology collaborate on first edition framework for CADScor System
May 2, 2023
Acarix to present at the 2023 Aktiespararna Share Day in Stockholm
- User manual US-FDA v.12.Y, prevalence 10,7%
- Winther S, et al. Heart 2018;104:928–935 (Dan-NICAD I)
- Based on commercial patch use since 2017